Creo Medical eyes strong growth in 2025 after upbeat start to year
Creo Medical Group PLC (AIM:CREO) has reported a positive start to 2025 following strong first-quarter sales of its Speedboat UltraSlim and newly launched Speedboat Notch devices, as the medical technology group targets up to 60% growth in its core revenue …